Curtis Gale Oltmans Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Curtis Gale Oltmans.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Curtis Gale Oltmans. Curtis Gale Oltmans is General Counsel in ARRAY BIOPHARMA INC ($ARRY).
Latest Insider Trading Transactions of Curtis Gale Oltmans
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 07 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | M | 8.94 | 40,000 | 357,600 | 363,900 | |
| Feb 07 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Sell | S | 20.00 | 40,000 | 800,000 | 15,021 | 55 K to 15 K (-72.70 %) |
| Feb 07 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 8.94 | 40,000 | 357,600 | 55,021 | 15 K to 55 K (+266.29 %) |
| Feb 07 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 8.94 | 11,100 | 99,234 | 15,021 | 3.9 K to 15 K (+283.09 %) |
| Jan 29 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | M | 8.94 | 11,100 | 99,234 | 403,900 | |
| Jan 29 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | M | 8.94 | 14,029 | 125,419 | 415,000 | |
| Jan 29 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Sell | S | 18.00 | 14,029 | 252,523 | 3,921 | 18 K to 3.9 K (-78.16 %) |
| Jan 29 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 8.94 | 14,029 | 125,419 | 17,950 | 3.9 K to 18 K (+357.79 %) |
| Jan 23 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | M | 8.94 | 1,251 | 11,184 | 429,029 | |
| Jan 23 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | M | 8.94 | 1,251 | 11,184 | 429,029 | |
| Jan 23 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Sell | S | 18.00 | 1,251 | 22,518 | 3,921 | 5.2 K to 3.9 K (-24.19 %) |
| Jan 23 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Sell | S | 18.00 | 1,251 | 22,518 | 3,921 | 5.2 K to 3.9 K (-24.19 %) |
| Jan 23 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 8.94 | 1,251 | 11,184 | 5,172 | 3.9 K to 5.2 K (+31.91 %) |
| Jan 23 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 8.94 | 1,251 | 11,184 | 5,172 | 3.9 K to 5.2 K (+31.91 %) |
| Jan 17 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | M | 8.94 | 19,720 | 176,297 | 430,280 | |
| Jan 17 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Sell | S | 18.06 | 19,720 | 356,139 | 3,921 | 23.6 K to 3.9 K (-83.41 %) |
| Jan 17 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 8.94 | 19,720 | 176,297 | 23,641 | 3.9 K to 23.6 K (+502.93 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | M | 0.00 | 7,000 | 0 | 21,000 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | A | 15.97 | 116,250 | 1,856,513 | 116,250 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | A | 0.00 | 19,375 | 0 | 19,375 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Payment of Exercise | F | 15.97 | 3,079 | 49,172 | 3,921 | 7 K to 3.9 K (-43.99 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
| Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | A | 8.94 | 450,000 | 4,023,000 | 450,000 | |
| Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | A | 10.92 | 168,000 | 1,834,560 | 168,000 | |
| Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | A | 0.00 | 28,000 | 0 | 28,000 |
Page: 1